Repligen (RGEN) Fails to deliver data

Key failure to deliver metrics for Repligen :

• Last SEC data release: 2025-02-28
• Last 15 days FTD volume: A$2.17 M
• Last 3 months FTD volume: A$5.06 M
• Last year FTD volume: A$5.06 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Repligen (RGEN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Repligen (RGEN) - since 2013

Repligen (RGEN) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Novavax NVAX	A$13.2 M	A$0.13 B	🇺🇸 USA
BioMarin Pharmaceutical BMRN	A$3.58 M	A$23.49 M	🇺🇸 USA
Neurocrine Biosciences NBIX	A$8.23 M	A$26.39 M	🇺🇸 USA
General Electric GE	A$0.27 B	A$1.43 B	🇺🇸 USA
Thermo Fisher Scientific TMO	A$18.62 M	A$0.17 B	🇺🇸 USA
Bristol-Myers Squibb BMY	A$0.17 B	A$0.49 B	🇺🇸 USA
Pfizer PFE	A$29.94 M	A$0.34 B	🇺🇸 USA
Bio-Techne TECH	A$0.28 M	A$20.17 M	🇺🇸 USA
Sangamo Therapeutics SGMO	A$1.19 M	A$6.43 M	🇺🇸 USA
Charles River Laboratories CRL	A$10.01 M	A$52.43 M	🇺🇸 USA